QT Vascular in US$13.14m convertible debt investment to fund growth
QT Vascular, a developer of minimally invasive products for the treatment of vascular diseases, has entered into a US$13.14 million convertible debt investment to fund its next growth phase.
This comes less than a month after the company entered into a US$12 million convertible bond investment to further develop its Drug-Coated Chocolate platform.
On Friday, the counter closed down 0.84 per cent, or 0.1 Singapore cent, at S$0.118.
Share with us your feedback on BT's products and services
TRENDING NOW
What shattered Crystal Jade? How the culinary empire shrank from 120 to just 9 outlets
Could Jensen Huang work for Elon Musk? It would be ‘a titanic ego death match’, says biographer
South-east Asia has lost Nvidia’s best salesman
Nvidia’s Jensen Huang fallout is a gift to billionaires Ambani and Adani